alopecia

Search with Google Search with Bing
Information
Disease name
alopecia
Disease ID
DOID:987
Description
"A hypotrichosis that is characterized by a loss of hair from the head or body." [url:http\://en.wikipedia.org/wiki/Alopecia, url:http\://www.omim.org/entry/109200?search=109200&highlight=109200]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT04721548 Active, not recruiting Phase 3 Treatment of Androgenetic Alopecia in Men for 24 Weeks March 2, 2023 September 30, 2024
NCT04459650 Active, not recruiting Early Phase 1 A Study of PRP Treatment for Hair Loss After Cancer Therapy in Women With Breast Cancer June 23, 2020 June 2024
NCT03382184 Active, not recruiting Early Phase 1 Fractional Photothermolysis for Hair Follicle Induction October 20, 2017 December 2026
NCT00441116 Completed Phase 3 A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia December 15, 2006 January 21, 2008
NCT00515762 Completed Phase 2 Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling May 2007 June 2010
NCT01590238 Completed Phase 3 Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM) May 2012 November 2013
NCT00177099 Completed Phase 1 Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice July 2003 September 2004
NCT00179348 Completed N/A Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer February 8, 2001 July 20, 2016
NCT01004809 Completed AVODART® Alopecia Post-marketing Surveillance (PMS) April 29, 2010 December 21, 2012
NCT01008774 Completed N/A START: Swiss Taxotere Alopecia Prevention Trial July 2009 October 2011
NCT01145625 Completed Phase 3 Clinical Trial in Females With Female Pattern Hair Loss June 2010 February 2012
NCT01189279 Completed Phase 1 Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia October 2010 February 2011
NCT01325337 Completed Phase 2 Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia June 2011 September 2012
NCT01325350 Completed Phase 2 Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss June 2011 September 2012
NCT01831791 Completed Phase 3 A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia April 14, 2013 July 19, 2014
NCT01904721 Completed Phase 2 A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA) August 2013 January 2015
NCT01929330 Completed Phase 1 Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male Volunteers September 23, 2013 January 9, 2014
NCT02014584 Completed Phase 3 Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia July 2, 2014 March 19, 2016
NCT02206802 Completed Minoxidil Response Testing in Females With Female Pattern Hair Loss July 2014 October 2018
NCT02605629 Completed N/A EValuation of the Impact of a TOpical Lotion on Permanent Chemotherapy Induced Hair Disorders in Cancer Survivors July 13, 2016 June 9, 2017
NCT02781311 Completed Phase 2 A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males July 14, 2016 May 22, 2018
NCT02793557 Completed Phase 1/Phase 2 Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth January 2016 March 2017
NCT02919735 Completed Phase 2 Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN) October 2016 March 1, 2019
NCT02986412 Completed N/A A 6-month Post-interventional Follow-up Extension of VOLUME Study (VOLUME-2) January 15, 2016 December 15, 2017
NCT03331003 Completed N/A "iRestore" Light Therapy Apparatus March 30, 2015 December 15, 2016
NCT03351322 Completed Phase 2 ENERGI-F701 for Female Hair Loss Treatment May 23, 2018 December 26, 2019
NCT03488108 Completed Phase 1/Phase 2 Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women January 23, 2017 June 17, 2019
NCT03594227 Completed Phase 2 ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis June 11, 2018 June 18, 2019
NCT03689452 Completed N/A The Effect of Platelet Rich Plasma on Non-scarring Alopecia October 1, 2018 June 3, 2019
NCT04117815 Completed Hair-Safe Study: Scalp Cooling for Hair Saving in Women Undergoing Chemotherapy May 18, 2018 February 28, 2021
NCT04205214 Completed N/A A Randomised Control Trial of Integrative Cognitive Behavioural Therapy for Alopecia December 1, 2018 February 13, 2020
NCT04246957 Completed Quality of Life Comparison in Patients With Different Types of Alopecia March 4, 2019 November 16, 2020
NCT04492800 Completed N/A Hair Loss Prevention Study for Pancreatic Cancer December 13, 2019 December 31, 2021
NCT04554732 Completed Early Phase 1 Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced Alopecia April 27, 2020 June 24, 2022
NCT04805606 Completed Phase 1 A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843 April 30, 2021 December 24, 2021
NCT04897555 Completed N/A LLLT for Alopecia of the Eyebrow in Women May 1, 2019 October 1, 2019
NCT05218642 Completed Phase 2 To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia January 31, 2022 February 13, 2023
NCT05587699 Completed Phase 1 The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A November 15, 2022 October 17, 2023
NCT05589610 Completed Phase 2 Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata December 19, 2022 April 30, 2024
NCT05630027 Completed A Scalp Lotion Toimprove Sensitive Scalp Syndrome January 2, 2019 June 30, 2020
NCT06095739 Completed N/A Study to Investigate the Effectiveness of a Topical Cosmetic Formulation DA-OTC-002 November 18, 2022 January 2, 2023
NCT06409650 Completed Phase 2 To Evaluate Safety and Efficacy of KX-826 in Chinese Female Subjects With Androgenetic Alopecia November 9, 2021 December 7, 2023
NCT05484973 Not yet recruiting N/A Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss March 31, 2024 September 30, 2025
NCT05544448 Not yet recruiting N/A In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases October 15, 2022 April 15, 2023
NCT06355856 Not yet recruiting Phase 4 Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss April 2024 May 2025
NCT06292533 Not yet recruiting N/A Effectiveness of Ultrapulse for the Treatment of Androgenic Alopecia Among Malaysian: A Quasi-experimental Study June 2024 October 2024
NCT06283316 Recruiting Systemic Treatments for Alopecia Areata Registry January 17, 2024 December 31, 2099
NCT06215469 Recruiting N/A Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads) May 16, 2024 August 31, 2025
NCT03840928 Recruiting PatientSpot Formerly Known as ArthritisPower April 1, 2015 March 1, 2025
NCT04014413 Recruiting N/A Safety and Efficacy of Fecal Microbiota Transplantation July 15, 2019 October 31, 2030
NCT05658094 Recruiting N/A Exosome Effect on Prevention of Hairloss August 1, 2022 October 29, 2023
NCT05723198 Recruiting Phase 3 A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata February 27, 2023 August 2029
NCT04764357 Recruiting N/A Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors June 4, 2021 December 2025
NCT05778825 Recruiting Phase 2 A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors March 10, 2023 March 2026
NCT05779527 Recruiting N/A Mindful Parenting - A Single Case Experimental Design Study January 3, 2023 April 14, 2023
NCT05213936 Recruiting N/A Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color October 24, 2022 January 2025
NCT02935569 Terminated N/A Compression Headband Use to Prevent Hair Loss During Whole Brain Radiotherapy May 2012 August 2014
NCT00713154 Terminated Phase 2 Safety and Preliminary Efficacy Study of MTS-01 for the Prevention of Alopecia Induced by WHole Brain Radiotherapy April 2007 September 2008
NCT00129415 Terminated Phase 1/Phase 2 Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions August 2000 January 2011
NCT01367990 Terminated Phase 1 Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy July 2011 April 2012
NCT05761158 Terminated Study of the Characteristics of Pruritus in Patients With Frontal Fibrosing Alopecia or Lichen Planus Pilaris March 14, 2023 May 25, 2023
NCT01385839 Terminated N/A Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata October 2009 May 2012
NCT02676310 Terminated Phase 1 Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA) March 2016 March 2017
NCT00418249 Unknown status Phase 2 Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women
NCT02591823 Unknown status Hair Fall in Patients on Low Dose Methotrexate October 2015 May 2016
NCT02393040 Unknown status N/A Study to Assess Efficacy of Platelet-Rich Plasma in Androgenetic Alopecia January 2014 November 2015
NCT01557491 Unknown status N/A Hair Regrowth After Bicoronal Incision May 2012
NCT01651689 Unknown status Hair Counts From Vertical and Horizontal Sections of Scalp Biopsy SPecimens in Thai Population With Alopecia October 2010 May 2013
NCT00197379 Unknown status N/A The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia May 2005 January 2007
NCT01986140 Unknown status N/A Scalp Cooling to Prevent Chemo-induced Hair Loss May 15, 2014 December 2022
NCT03662854 Unknown status Phase 1 Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss July 2, 2018 January 21, 2021
NCT04834102 Unknown status COVID-19 Induced Telogen Effluvium January 27, 2021 April 27, 2021
NCT03427905 Unknown status N/A Autologous Adipose-Derived Adult Stromal Vascular Cell Transplantation for Alopecia January 27, 2017 December 30, 2018
NCT01111981 Unknown status Phase 4 Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia October 2009 October 2010
NCT00801086 Unknown status Phase 2 Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain November 2008 June 2010
NCT04953416 Unknown status N/A Fractional Non-ablative Laser for the Treatment of Hair Loss September 8, 2020 March 2022
NCT05129800 Unknown status Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study December 2021 February 2022
NCT02856308 Unknown status N/A Hairstetics Hair Implant Device Safety and Efficacy March 2014 September 2018
NCT05210452 Unknown status Phase 1/Phase 2 Treatment of Alopecia Using Follicular Stem Cells March 1, 2022 December 31, 2023
NCT04036994 Unknown status N/A PBMT for the Management of CIA ( HAIRLASER ) June 17, 2020 December 31, 2022
NCT05365243 Withdrawn N/A A Pilot Study to Evaluate the Use of the AMMA Portable Scalp Cooling System From Cooler Heads August 15, 2022 September 30, 2023
NCT00999557 Withdrawn N/A Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants January 2016
NCT03284021 Withdrawn N/A Fraxel Laser for Alopecia April 24, 2019 April 24, 2019
Disase is a (Disease Ontology)
DOID:4535
Cross Reference ID (Disease Ontology)
ICD10CM:L65.9
Cross Reference ID (Disease Ontology)
ICD9CM:704.0
Cross Reference ID (Disease Ontology)
MESH:D000505
Cross Reference ID (Disease Ontology)
MIM:PS203655
Cross Reference ID (Disease Ontology)
NCI:C50575
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:270504008
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0002170
HPO alt_id (Human Phenotype Ontology)
HP:0002238
HPO alt_id (Human Phenotype Ontology)
HP:0008068
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0001596
MeSH unique ID (MeSH (Medical Subject Headings))
D000505